Abstract

Although Vinorelbine (VOB) is a powerful anticancer medication, it inevitably has a number of adverse effects. Therefore, identifying this medication in biological samples is crucial for assessing both its effectiveness and negative effects. In this study, a new DNA biosensor was created to analyze VOB within biological samples. Moreover, the sensor has been created though the modification of a pencil graphite electrode (PEG) with polypyrrole (PP), a woolen ball-shaped La3+/TiO2 nanostructure (WB–S La3+/TiO2-NS) (enhancing the conductivity of electricity), along with ds-DNA (calf thymus) (ds-DNA/PP/WB-S La3+/TiO2-NS/PGE). Alterations in electrode signal has been then utilized to determine whether VOB is present. Under optimized condition, the differential pulse voltammetry (DPV) and electrochemical impedance spectroscopy (EIS) techniques were adopted for electrochemical sensing of VOB. With a 0.37 nM detection limit, ds-DNA/PP/WB-S La3+/TiO2-NS/PGE demonstrated remarkable sensitivity for VOB at concentrations between 0.001 and 150.0 μM by DPV method. In addition, the calibration curve shows a linear range between 5.0 and 100.0 μM vanillin with a detection limit of about 0.76 μM by EIS method. Theoretical docking investigation was used to analyze the contacts among VOB and ds-DNA bases for future assessments, and the results supported the intercalation of VOB with guanine bases ds-DNA's intercalations. VOB was examined using the ds-DNA/PP/WB-S La3+/TiO2-NS/PGE method in actual samples.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call